Unraveling Attributes of COVID-19 Vaccine Hesitancy and Uptake in the U.S.: A Large Nationwide Study
McCabe, S.; Hammershaimb, E. A. D.; Cheng, D.; Shi, A.; Shyr, D.; Shen, S.; Cole, L. D.; Cataldi, J. R.; Allen, W.; Probasco, R.; Silbermann, B.; Zhang, F.; Marsh, R.; Travassos, M.; Lin, X.
Show abstract
SARS-CoV-2 vaccines are powerful tools to combat the COVID-19 pandemic, but vaccine hesitancy threatens these vaccines effectiveness. To address COVID-19 vaccine hesitancy and ensure equitable distribution, understanding the extent of and factors associated with vaccine acceptance and uptake is critical. We report the results of a large nationwide study conducted December 2020-May 2021 of 34,470 users from COVID-19-focused smartphone-based app How We Feel on their willingness to receive a COVID-19 vaccine. Nineteen percent of respondents expressed vaccine hesitancy, the majority being undecided. Of those who were undecided or unlikely to get a COVID-19 vaccine, 86% reported they ultimately did receive a COVID-19 vaccine. We identified sociodemographic and behavioral factors that were associated with COVID-19 vaccine hesitancy and uptake, and we found several vulnerable groups at increased risk of COVID-19 burden, morbidity, and mortality were more likely to be vaccine hesitant and had lower rates of vaccination. Our findings highlight specific populations in which targeted efforts to develop education and outreach programs are needed to overcome vaccine hesitancy and improve equitable access, diversity, and inclusion in the national response to COVID-19.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Racial and ethnic differences in COVID-19 vaccine hesitancy and uptake 96%
- Strength and durability of indirect protection against SARS-CoV-2 infection through vaccine and infection-acquired immunity 94%
- Vaccine uptake and SARS-CoV-2 antibody prevalence among 207,337 adults during May 2021 in England: REACT-2 study 94%
Similar papers in this journal
- Rapid emergence of SARS-CoV-2 Omicron variant is associated with an infection advantage over Delta in vaccinated persons 94%
- Real-time analysis of a mass vaccination effort via an Artificial Intelligence platform confirms the safety of FDA-authorized COVID-19 vaccines 93%
- FDA-authorized COVID-19 vaccines are effective per real-world evidence synthesized across a multi-state health system 92%
Similar papers in this journal
- Adherence and sustainability of interventions informing optimal control against COVID-19 pandemic 90%
- The prevalence of SARS-CoV-2 infection and other public health outcomes during the BA.2/BA.2.12.1 surge, New York City, April-May 2022 90%
- Spatial analysis of COVID-19 booster vaccine uptake in Scotland, and projection of future distributions 89%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.